← Insider buys
KPTI

Karyopharm Therapeutics Inc. · Healthcare

Chief Dev Operations Officer Ran Frenkel sold $33K of Karyopharm Therapeutics Inc.

Sold$33,286
$10.06Price
3,309Shares
−18%Stake

What KPTI did after the filing

Prices for KPTI after this filing aren't in yet.

Traded Mon, Nov 14. Filed Tue, Nov 15, 11:05 AM ET, during the session. Not investment advice.